Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The treatment improved hair growth and thickness in patients with hair loss, even 10 months after therapy without additional products.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Clascoterone may be a promising treatment for hair loss.

Current treatments for androgenetic alopecia have limitations, and personalized approaches and new methods are needed for better results.

Treatments for hair loss include hormone modifiers, minoxidil, and hair transplant surgery.

Finasteride, a drug used for certain conditions, can cause serious side effects like sexual dysfunction, suicidal thoughts, and increased diabetes risk, and there's a need for more awareness and research about these effects.

Minoxidil, finasteride, and hair transplantation combined give best results for hair loss.

Minoxidil, finasteride, and hair transplantation combined give best results for hair loss.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Finasteride reduces new brain cells in male mice, possibly causing depression.

The document explains various skin conditions and their treatments.

Men with male-pattern baldness have higher levels of certain testosterone metabolites and may have more active androgen metabolism.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

New Finasteride conjugate improves prostate treatment and vital signs in rats.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Male pattern baldness involves genetics, hormones, and needs better treatments.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Finasteride worsens seizures in epilepsy rats and speeds up epileptogenesis in mice.

Finasteride significantly reduces hair growth in women with idiopathic hirsutism.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

The nutritional supplement improved hair quality and reduced hair loss.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.